Author

Roza H. Ali Masalmeh

Cancer Research UKORCID 0000-0002-6079-5066Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

John C. DawsoniD· 2 shared Margaret C. FrameiD· 2 shared Neil O. CarragheriD· 2 shared Steven M. PollardiD· 2 shared Valerie G. BruntoniD· 2 shared Virginia Alvarez GarciaiD· 2 shared Alex von KriegsheimiD· 1 shared Alison F. MunroiD· 1 shared

Activity by Year

2021-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

John C. DawsonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyDisease Models & MechanismsPeer-reviewedSep 22, 2025

FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation

Roza H. Ali Masalmeh, John C. Dawson, Virginia Alvarez Garcia…·Margaret C. Frame

This study shows FAK regulates glycolysis and glutamine oxidation in glioblastoma stem cells, affecting mitochondrial morphology and cell migration.

10 citationstop 4%

mouseproteomics

𝕏 PostBluesky

Cancer BiologyPharmaceuticsPeer-reviewedApr 23, 2025

Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma

Muhammad Furqan, Richard J. R. Elliott, Peter W. Nagle…·Neil O. Carragher

This study identifies a synergistic combination of FAK and MEK inhibitors that effectively targets glioblastoma heterogeneity and improves therapeutic outcomes.

11 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky

GeneticsNature CommunicationsPeer-reviewedJan 29, 2021

De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands

Roza H. Ali Masalmeh, Francesca Taglini, Cristina Rubio-Ramon…·Duncan Sproul

The paper shows de novo DNA methyltransferases in colorectal cancer target H3K36me3-marked CpG islands, similar to normal tissues, rather than sequence-specific CpG islands.

55 citations

humanDNA methylation

𝕏 PostBluesky